It has been a tumultuous 2020 for venture capital and mergers and acquisitions due to the market uncertainty sparked by the onset of the coronavirus pandemic. Companies seeking acquisitions and venture capital firms alike continue to find their footing, as do the life science companies progressing toward important milestones during a global public health crisis.
Image: https://biobuzz.io
{iframe}https://biobuzz.io/biohealth-capital-region-m-a-roundup-first-half-of-2020/{/iframe}